1
|
Cuesta Esteve I, Fernández Fernández P, López Palacios S, Menor Rodríguez MJ, Parra Vino H, Reyero Ortega B, Nieto Nevot ML, Drago Manchón G, López-Belmonte JL. Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain. Prev Med Rep 2021; 22:101376. [PMID: 33996389 PMCID: PMC8105659 DOI: 10.1016/j.pmedr.2021.101376] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 02/09/2021] [Accepted: 03/21/2021] [Indexed: 11/30/2022] Open
Abstract
Biosafety devices are needed to safely administer vaccines. Use of “ready-to-use” vaccines can avoid biological accidents. Majority of nurses showed concerns about using lyophilized vaccines.
Vaccination is an effective health intervention for the prevention of infectious diseases. This study aims to evaluate the response provided by nurses toward the use of ready-to-use (RTU) formulations of hexavalent vaccines and measures to prevent errors during the vaccination process. This observational, descriptive, cross-sectional study took place from March to May 2018. It included 201 interviews with nurses from health centers in Madrid (70), Murcia (59), and Andalusia (72), who had administered RTU vaccines in the last 12 months. Approximately 91.6% of nurses provided a positive feedback for the use of RTU vaccines. The most significant concerns experienced by nurses were during the preparation and administration of vaccines; 84.1% versus 18.9% of nurses felt that the risk of making mistakes was lower while using RTU vaccines compared with non-reconstituted (lyophilized) vaccines, and 74.1% versus 22.4% of nurses felt ease at preparing RTU vaccines compared with lyophilized vaccines. A total of 66.7% of nurses believed that there were risks associated with the preparation of lyophilized vaccines (administration risk [42.8%] and risk of needle injury [42.3%]). Risk percentages reduced to 4% and 9.5%, respectively, with the use of the RTU vaccines. Therefore, nurses adopted an average of seven steps to reduce the risk of errors. The average time saved during the administration of the vaccines was 1.1 min. In summary, nurses highlighted the need for administering vaccines using RTU formulations for ensuring the safety of the recipients, preventing errors, and saving time during the vaccination process.
Collapse
Key Words
- DTPa HBV-IPV, diphtheria-tetanus-acellular pertussis-hepatitis B recombinant (adsorbed)-inactivated poliomyelitis-adsorbed conjugated Haemophilus influenzae type b vaccine
- DTaP, diphtheria, tetanus, and acellular pertussis (whooping cough)
- HB, hepatitis B
- HCP, healthcare professionals
- HPV, human papillomavirus
- Hib, Haemophilus influenzae type b
- ICC/ESOMAR, International Chamber of Commerce/European Society for Opinion and Market Research
- IPV, inactivated polio vaccine
- Lyophilized vaccines
- MM, measles, mumps
- MMR, measles, mumps, rubella
- Medication errors
- MenACWY, meningococcal conjugate vaccine
- MenC, meningococcal C vaccine
- PCV, pneumococcal conjugate vaccine
- Pediatric vaccination
- Primary healthcare
- RTU, ready-to-use
- Ready-to-use vaccines
- Td, tetanus, diphtheria
- Vaccination
- WHO, World Health Organization
Collapse
Affiliation(s)
- Inmaculada Cuesta Esteve
- Vaccine Expert Group of the General Council of Nurses, Calle Fuente del Rey, s/n, 28023 Madrid, Spain
| | | | - Sonia López Palacios
- Vaccine Expert Group of the General Council of Nurses, Calle Fuente del Rey, s/n, 28023 Madrid, Spain
| | | | - Hosanna Parra Vino
- Group of the General Council of Nurses, Calle Fuente del Rey, s/n, 28023 Madrid, Spain
| | - Begoña Reyero Ortega
- Group of the General Council of Nurses, Calle Fuente del Rey, s/n, 28023 Madrid, Spain
| | | | - Georgina Drago Manchón
- Sanofi Pasteur, Calle de Josep Pla, 2, 08019 Barcelona, Spain
- Corresponding author at: Sanofi Pasteur, Calle de Josep Pla, 2, 08019 Barcelona, Spain.
| | | |
Collapse
|
2
|
Ricós C, Álvarez V, Perich C, Fernández-Calle P, Minchinela J, Cava F, Biosca C, Boned B, Doménech M, García-Lario JV, Simón M, Fernández PF, Diaz-Garzón J, González-Lao E. Rationale for using data on biological variation. ACTA ACUST UNITED AC 2015; 53:863-70. [DOI: 10.1515/cclm-2014-1142] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Accepted: 03/31/2015] [Indexed: 11/15/2022]
Abstract
AbstractThe aims of this study are: 1) to use the data included in the biological variation (BV) database to address the usability of BV estimates; and 2) to use different examples from the authors’ laboratories to illustrate the use and the usefulness of BV data in laboratory medicine. The BV database is an essential tool for laboratory management. Examples of application of data derived from BV are given in this paper, such as analytical performance specifications that have been included in various quality control software designed to optimize operative rules; also they have been incorporated as acceptability limits in external quality assurance reports. BV data from pathological status are of utmost interest for monitoring patients and differences between the intra-individual coefficients of variation (CV
Collapse
|